Efficacy and Safety Study of Deferasirox in Patients With Non-transfusion Dependent Thalassemia
Clinical trial NCT01709838 · COMPLETED
Trial details
- NCT number
- NCT01709838
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-06
- Primary completion
- 2015-01-03
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.